BDBM50010181 CHEMBL2370402::[16-Acetylamino-4-carbamoyl-13-(4-guanidino-butyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid
SMILES [#6]-[#6](=O)-[#7]-[#6@@H]-1-[#6]-[#16]-[#16]C([#6])([#6])[#6@@H](-[#7]-[#6](=O)-[#6@@H](-[#6]-[#6](-[#8])=O)-[#7]-[#6](=O)-[#6]-[#7]-[#6](=O)-[#6@@H](-[#6]-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#7]-[#6]-1=O)-[#6](-[#7])=O
InChI Key InChIKey=VWGTZFRRIPINRY-WBOJAVRRSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50010181
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Smithkline Beecham Pharmaceuticals Research And Development
Curated by ChEMBL
Affinity DataIC50: 3.85E+5nMAssay Description:Inhibition of 125[I] Fibrinogen binding to isolated purified human fibrinogen receptorMore data for this Ligand-Target Pair